baber/WOPTO huggingface dataset:
Patent CA-2548546-A1 (CA)
Title: Method for storing, authenticalting and executing an application program
Inventor: SHIOMI TAKAKAZU
IPC: H04N21/235
Filed: 2004-12-15
Abstract: Conventionally, when the version of a program has been upgraded, the whole of a currently stored program needs to be deleted to be replaced by a new program, and authentication needs to be performed again on such new program when it is activated. However, since the whole of the program is required to be stored and authenticated even when only a part of such program has changed, it consumes time and leads to the decrease in responsiveness. In order to solve this problem, the present invention extracts a difference between a new program and a currently stored old program, when such new program is to be stored, and the new program is to be stored after authentication is performed only on such difference.
Patent CA-2548551-A1 (CA)
Inventor: DAVOL PAMELA A
IPC: G01N33/574
Filed: 2004-10-13
Abstract: This invention provides methods for treating a subject afflicted with a proliferative disorder comprising administering to the subject a therapeutically effective amount of an agent which inhibits the expression of p46 Shc and/or p52 Shc, inhibits the activity of p46 Shc and/or p52 Shc in the subject, or increases the level of phosphorylated p66 Shc in the subject. This invention also provides methods for determining whether an agent inhibits the phosphorylation of p46 Shc or p52 Shc; inhibits dephosphorylation of p66 Shc comprising; or an agent inhibits the binding of a Shc A protein with a protein to which the Shc A protein must bind in a cell in order to carry out its proliferative function. This invention also provides articles of manufacture for use in treating a proliferative disorder in a subject.
Patent CA-2548890-A1 (CA)
Title: Mixing impeller and method with weld locations
Inventor: GIGAS BERND
IPC: B01F29/84
Filed: 2006-05-30
Abstract: An impeller blade for a top skin element joined to a bottom skin element. The blade can have an air foil shape. A pre-shaped tip is joined to the radial outside end of the blade.
Patent CA-2549160-A1 (CA)
Title: Treatment and preventions of asthma
Inventor: COCHRANE CHARLES G
IPC: A61K31/00
Filed: 2004-12-03
Abstract: The invention provides compositions and methods for treating asthmatic conditions. Such compositions and methods utilize a lung surfactant mixture comprising a lung surfactant polypeptide.
Patent CA-2550347-A1 (CA)
Inventor: PITCHER DANIEL WILLIAM
IPC: B65G51/03
Filed: 2006-06-16
Abstract: The present invention relates to an improved rail that may be utilized in hydrostatic bearing levitation system, and manufacturing method thereof.  Hydrostatic bearing levitation systems uses fluid pressure to support and guide heavy loads as they move along a track system. Improvement comprises use of suitable aluminum alloy and hard anodizing coating with polyterafluoroethylene sealing.
Patent CA-2550907-A1 (CA)
Inventor: NORTON DAVE
IPC: G06Q30/02
Filed: 2006-06-27
Abstract: A program for rewarding players for gaming at a casino establishment provide s a player with real-time incentives while the player is playing at a gaming machine in the casino. Information about the player and/or the player's gaming activity is collected while the player is at a gaming machine in a casino. This information is use d by a marketing system to select an incentive to provide to the player. The incentive is then delivered to the player, for example manually by a casino employee or automatically using a printer or other mechanism at the gaming machine. Various types of incentives can be provided to a player, including incentives designed to provide the player with an experience that is favorable to the casino and incentives designed to keep t he player gaming in a casino for a longer amount of time.
Patent CA-2552569-A1 (CA)
Inventor: PARTHIBAN LAKSHMAN JAYANTH
IPC: A61K9/20
Filed: 2005-01-17
Abstract: Dipeptidylpeptidase IV inhibitor (herein referred to as DPP-IV) that may be 98.5-100% pure is a high-dose drug capable of being directly compressed with specific excipients into sold form dosage forms, such as tablets and capsules having desired, hardness, disintegrating ability and acceptable dissolution characteristics. DPP-IV is not inherently compressible and thus presents formulation problems. Excipients used in the formulation enhance the flow and compaction properties of the drug and tableting mix. Optimal flow contributes to uniform die fill and weight control. The binder used ensures sufficient cohesive properties that allow DPP-IV to be compressed using the direct compression method. The tablets produced provide an acceptable in vitro dissolution profile.
Patent CA-2553586-A1 (CA)
Inventor: NAKAMURA KEIICHI
IPC: C21D8/10
Filed: 2005-01-28
Abstract: A high-strength seamless steel pipe for oil wells excellent in sulfide stress cracking resistance which comprises, on the percent by mass basis, C: 0.1 to 0.20%, Si: 0.05 to 1.0%, Mn:  0.05 to 1.0%, Cr: 0.05 to 1.5%, Mo: 0.05 to 1.0%, Al: 0.10% or less, Ti: 0.002 to 0.05% and B: 0.0003 to 0.005%, with a value of equation "C + (Mn/6) + (Cr/5) + (Mo/3)" of 0.43 or more, with the balance being Fe and impurities, and in the impurities P:  0.025% or less, S: 0.010% or less and N: 0.007% or less. The seamless steel pipe may contain a specified amount of one or more element(s) of V and Nb, and/or a specified amount of one or more element(s) of Ca, Mg and REM. The seamless steel pipe can be produced at a low cost by adapting an in-line tube making and heat treatment process having a high production efficiency since a reheating treatment for refinement of grains is not required.
Patent CA-2553696-A1 (CA)
Title: Indazole-carboxamide compounds as 5-ht4 receptor agonists
Inventor: TURNER S DEREK
IPC: A61K31/496
Filed: 2005-02-17
Abstract: The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
Patent CA-2554055-A1 (CA)
Inventor: UCHITANI KOJI
IPC: B65D85/07
Filed: 2005-05-24
Abstract: A supply information management system (710) has a reader-writer (711) and a host computer (715) for receiving information from the reader-writer (711).  The reader-writer (711) is provided at each station for executing each process relating to the supply of a diaper product on which an IC tag (5) is attached, writes process information on each process into the IC tag (5), and reads information from the IC tag (5). In the host computer (715) is stored a product database that is the assembly of data elements associating the serial number of the IC tag (5) and process information, and the product data base is updated based on the information from the reader-writer (711). The supply information management system (710) can specify individual diaper products and can manage information on the supply of the diaper products accurately and easily.
Patent CA-2554251-A1 (CA)
Inventor: CHO YOUNG-KOOK
IPC: B65D51/28
Filed: 2005-02-02
Abstract: A bottle cap, fastened to a bottle body having a mouth with an external thread formed around the outer circumferential surface of the mouth, is disclosed.  The bottle cap includes an opening unit inserted into the mouth and open at upper and lower ends thereof, with a cutting unit provided in a lower portion of the opening unit; an additive storage container having a main cap fastened to the mouth, and an additive storage part inserted into the opening unit, with a recess provided at the lower end of the additive storage part to receive therein the cutting unit, and a breakable part integrated with the lower end of the additive storage part to be cut by the cutting unit during rotation; and an upper cap which opens or closes the upper end of the additive storage container.
Patent CA-2554483-A1 (CA)
Inventor: SPIVEY RAYMOND R SR
IPC: B65D71/00
Filed: 2005-02-09
Abstract: A carton is provided for holding and positioning articles for easy access. The carton may also be used for dispensing articles that contain products such as food and beverages. The carton includes various unique features, including an opening feature that provides easy access to the articles, and a tilt feature (T) that positions the articles at the front end of the carton. Also provided is a carton blank, such as a paperboard blank, which is cut to a specific shape, and creased and scored, cut or perforated in specific areas. Methods for forming the blanks into cartons and for operating the opening and positioning features are also described.
Patent CA-2555702-A1 (CA)
Title: Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
Inventor: HELLERSTEIN MARC K
IPC: A61K49/00
Filed: 2005-02-22
Abstract: The methods described herein enable the evaluation of compounds on subjects to assess their therapeutic efficacy or toxic effects. The target of analysis is the underlying biochemical process or processes (i.e., metabolic process) thought to be involved in disease pathogenesis. Molecular flux rates within the one or more biochemical processes serve as biomarkers and are quantitated and compared with the molecular flux rates (i.e., biomarker) from control subjects (i.e., subjects not exposed to the compounds). Any change in the biomarker in the subject relative to the biomarker in the control subject provides the necessary information to evaluate therapeutic efficacy of an administered drug or a toxic effect and to develop the compound further if desired. In one aspect of the invention, stable isotope-labeled substrate molecules are administered to a subject and the label is incorporated into targeted molecules in a manner that reveals molecular flux rates through one or more metabolic pathways of interest. By this method, a comparison between subjects and control subjects reveals the effects of the chemical entity or entities on the biomarkers. This, in turn, allows for the identification of potential therapeutic uses or toxicities of the compound. Combinations of compounds can also be systematically evaluated for complementary, synergistic, or antagonistic actions on the metabolic pathways of interest, using the methods of the present invention as a strategy for identifying and confirming novel therapeutic or toxic combinations of compounds.
Patent CA-2557025-A1 (CA)
Inventor: SCHAEFLE CLAUDIA
IPC: G03G9/00
Filed: 2005-02-24
Abstract: According to the invention, in order to print on a recording medium (402), potential images of the images to be printed are produced on a potential image recording medium. Said potential images are developed on the potential image recording medium in order to form an image film, by means of a liquid developer consisting of a polymerisable carrier liquid containing suspended toner particles. The image film is than transferred to the recording medium (402) and fixed by the cross-linking of the carrier liquid. The toner particles are not melted.
Patent CA-2559495-A1 (CA)
Title: Multiple horizontal needle quilting machine and method
Inventor: FRAZER JAMES T
IPC: D05B1/00
Filed: 2005-03-11
Abstract: A multi-needle quilting machine (10) and method in which provided bridges (21,22) are provided having selectively operable stitching element pairs (90).  Either the material or the bridges or both may be moved relative to the frame.  Control schemes are provided to quilt continuous patterns, discrete patterns, linked multiple patterns, 360 degree patterns, closely spaced patterns. A  plurality of small presser feet (158) are provided, each for one or more needles (132), with a wide spacing for material passage between the needle and looper plates. Combinations of intermittent and continuous feed and feed transition are employed during tack sequence sewing and other direction reversals in sewing, as well as double needle guards and thread deflection.
Patent CA-2560627-A1 (CA)
Inventor: MILETICH DON
IPC: F21V19/00
Filed: 2006-09-22
Abstract: A lighting fixture includes a base having a hole in a top surface thereof, at least one retaining member disposed on the top surface of the base proximate the hole, a lamp housing having a top portion and a dome-shaped bottom portion, the bottom portion including a perimeter portion having an essentially planar annular end surface sized to surround the hole, at least one boss extending from the perimeter portion of the lamp housing, and a handle attached to the top portion of the lamp housing, where the retaining member is structured for receiving the boss with the annular end surface of the lamp housing abutting the top surface of the base and surrounding the hole, so that rotation of the handle effects twist-locking attachment or detachment of the lamp housing respectively to or from the base by rotating the boss into or out of engagement with the retaining member.
Patent CA-2563014-A1 (CA)
Inventor: STOKES MICHAEL
IPC: A61B17/072
Filed: 2006-10-10
Abstract: A surgical stapler is provided having a cartridge arm for holding staples, an anvil pivotally connected thereto to deform fired staples from the cartridge arm, and a support for substantially preventing anvil deflection during staple firing to help insure proper staple formation. Some supports allow pivoting between the anvil and cartridge arm when in a first position, but prevent or hinder the pivoting action when in a second position. Supports can also be adapted to contact the anvil at a distal position relative to the pivot point between the anvil and cartridge arm.  Exemplary structures of supports embodied as one or more links or as a sleeve are described.      Methods of use are also discussed.
Patent CA-2564359-A1 (CA)
Inventor: LOTT ROGER K
IPC: C10G65/04
Filed: 2005-04-28
Abstract: A fixed bed hydroprocessing system, and also a method for upgrading a pre-existing fixed bed hydroprocessing system, involves preliminarily upgrading a heavy oil feedstock in one or more slurry phase reactors using a colloidal or molecular catalyst and then further hydroprocessing the upgraded feedstock within one or more fixed bed reactors using a porous supported catalyst. The colloidal or molecular catalyst is formed by intimately mixing a catalyst precursor composition into a heavy oil feedstock and raising the temperature of the feedstock to above the decomposition temperature of the precursor composition to form the colloidal or molecular catalyst in situ. Asphaltene or other hydrocarbon molecules otherwise too large to diffuse into the pores of the fixed bed catalyst can be upgraded by the colloidal or molecular catalyst.  One or more slurry phase reactors may be built and positioned upstream from one or more fixed bed reactors of a pre-existing fixed bed system and/or converted from one or more pre-existing fixed bed reactors.
Patent CA-2565387-A1 (CA)
Inventor: HUY DAVID
IPC: A61K39/395
Filed: 2005-05-03
Abstract: The present invention provides methods for the treatment of lysophosphatidylcholine-related conditions. In particular, the invention provides a method of treating an insulin-related condition, e.g., diabetes or diabetes type 2, and/or a weight-related-condition, e.g., unwanted weight gain or obesity, in an animal subject by reducing production, absorption and/or activity of lysophosphatidylcholine. Further, the beneficial effects of reducing lysophosphatidylcholine in terms of diabetes and weight gain are disclosed.
Patent CA-2565459-A1 (CA)
Inventor: SPADA LON T
IPC: A61K9/22
Filed: 2005-04-28
Abstract: Biocompatible intraocular implants include an anti-excitotoxic agent and a polymer that is effective to facilitate release of the anti-excitotoxic agent into an eye for an extended period of time. The therapeutic agents like NMDA  receptor anragonists like adamantine or memantine may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants may be placed in an eye to treat or reduce the occurrence of one or more ocular conditions, such as retinal damage, including glaucoma and proliferative vitreoretinopathy.
Patent CA-2565905-A1 (CA)
Title: Gum slab package with flap retention
Inventor: ALDRIDGE ALLEN SYDNEY
IPC: B65D85/60
Filed: 2005-05-09
Abstract: A package assembly (10) encloses a plurality of individual elongate consumable products (14). The package assembly includes a plurality of products aligned in a side-by-side array. A package housing (16) encloses the array of products. The package housing has front and back walls (18, 20) for supporting the products therebetween in a closable cover (30) for closing a product dispensing opening. The front wall includes a wall flap (119) extending inwardly towards the back wall in frictional engagement with the array of products for removable retention of the products therein.
Patent CA-2566095-A1 (CA)
Title: Stopcock for medical treatment
Inventor: IGUCHI MASANOBU
IPC: F16K5/08
Filed: 2006-10-30
Abstract: The present invention provides a medical valve unit having a main housing portion to which are attached a number of connection ports. At least one of the connection ports includes a connector which is releasably attachable to the housing and which is made of a material which offers a greater resistance to chemical degradation than a material from which the housing is fabricated.
Patent CA-2571932-A1 (CA)
Title: Multimodal method for identifying hazardous agents
Inventor: SCHWEITZER ROBERT
IPC: G01J3/44
Filed: 2005-06-30
Abstract: The invention relates to apparatus and methods for assessing occurrence of a hazardous agent in a sample by performing multimodal spectral analysis of the sample. Methods of employing Raman spectroscopy for entities in a sample which exhibit one or more optical properties characteristic of a hazardous agent are disclosed. Devices and systems suitable for performing such methods are also disclosed.
Patent CA-2572971-A1 (CA)
Title: Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
Inventor: VAN BRANDT SVEN FRANCISCUS ANN
IPC: C07D239/42
Filed: 2005-07-25
Abstract: This invention comprises the novel compounds of formula (I) wherein R1, R2, R3, R4 and X have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
Patent CA-2573755-A1 (CA)
Title: Training guidance system for canines, felines, or other animals
Inventor: KATES LAWRENCE
IPC: A01K15/02
Filed: 2005-06-17
Abstract: A computer-aided training and management system that uses a computer (103) or other processor in wireless communication with an instrumented dog collar and/or optionally, one or more dog interaction devices, such as, for example, video monitors (105) , loudspeakers (107) , video cameras (106) , training toys (e.g., ball (114) , bone (116), moving toy (115), etc.), an animatronics "trainer (123) ," a treat dispenser (122) , a food dispensing and monitoring device (121), a water dispensing and monitoring device (120) , tracking devices, a dog door (111) , dog-monitoring doghouse (119) , a dog-monitoring dog toilet (117) , is described. In one embodiment, the instrumented dog collar is in two-way communication with a central computer system.
Patent CA-2576896-A1 (CA)
Title: Carbon dioxide enriched flue gas injection for hydrocarbon recovery
Inventor: KRESNYAK STEVE
IPC: E21B43/24
Filed: 2007-02-05
Abstract: A process for enhanced oil and gas recovery. An enriched flue gas is synthesized from utility plant flue gas. The enriched flue gas is customizable for specific requirements; however, the gas is formed to have a high concentration of carbon dioxide. This is used as an injectant for enhancing the liberation of gas and/or oil from subterranean formations. The injection elevates recovery while sequestering carbon dioxide from the power plant source.
Patent CA-2578581-A1 (CA)
Inventor: TAN SHARON MI LYN
IPC: A61F2/06
Filed: 2005-07-11
Abstract: A composite vascular graft (10) incorporates bioactive agents to deliver therapeutic materials and/or inhibit or reduce bacterial growth during and following the introduction of the graft to the implantation site in a vascular system. A composite vascular graft includes a porous tubular graft member (12). One or more biodegradable, bioactive agent coating layers (14) are disposed over the graft member, the coating layer including at least one bioactive agent (16). A biodegradable sheath (18) is disposed over the coating layer. The sheath has a rigidity greater than the flexible tubular graft member and is biodegradable to expose the coating layer so as to reestablish the flexibility of the tubular graft member.
Patent CA-2579025-A1 (CA)
Title: A polymeric wrap for in vivo delivery of osteoinductive formulations
Inventor: SERBOUSEK JON C
IPC: A61L27/34
Filed: 2005-08-31
Abstract: The application discloses a polymeric wrap having one or more osteoinductive formulations, wherein each osteoinductive formulation comprises one or more osteoinductive agent(s). In one embodiment, the osteoinductive formulation(s) is contained within a biodegradable polymer sheet. In another embodiment of the invention, the polymeric wrap comprises at least two or more individual biodegradable polymer sheets or layers optionally comprising osteoinductive formulation(s) comprising at least one osteoinductive agent. The osteoinductive formulations are available in immediate or sustained release formulations. The method further relates to preventing and treating osteolytic lesions formed following implantation of an orthopaedic device or other implant.
Patent CA-2581221-A1 (CA)
Inventor: BECKMANN RUDI
IPC: F41A33/06
Filed: 2005-09-21
Abstract: Apparatus and methods are described for a weapon simulator. An example weapon simulator includes a pressure piston, which is couplable to a weapon, which acts to open a breech, and which is seated in a pressure cylinder. An example pressure piston includes a slider. The slider holds a pressure intake opening open and keeps one or more pressure outlet openings closed when the breech block is in a front-most position. In addition, the slider keeps the pressure intake opening closed and holds the one or more pressure outlet opening open when the breech block is in a rear-most position.
Patent CA-2581328-A1 (CA)
Inventor: SPECTOR MYRON
IPC: A61F13/00
Filed: 2005-09-21
Abstract: This invention relates to gradient scaffolds, methods of producing the same, and methods of use thereof, in particular for applications in tissue engineering, repair and regeneration. The gradient scaffolding includes, inter~-alia, scaffolds, which are varied in terms of their pore diameter, chemical composition, crosslink density, or combinations thereof, throughout the scaffolding.
Patent CA-2582247-A1 (CA)
Title: 3-arylamino pyridine derivatives
Inventor: SEKUL RENATE
IPC: A61P35/00
Filed: 2005-10-19
Abstract: The invention provides novel, substituted 3-arylamino pyridine compounds (I) pharmaceutically acceptable salts, solvates and prodrug compounds thereof, wherein W, R1, R2, R9, R10, R11, R12, R13, R14 are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer, restenosis and inflammation.  Also disclosed is the use of such compounds in the treatment of hyperproliferative diseases in mammals, especially humans, and pharmaceutical compositions containing such compounds.